NRx Pharmaceuticals announces positive safety report for Zyesami in NIH-sponsored ACTIV-3 study in… EP News Bureau Aug 21, 2021 ACTIV-3 Critical Care is evaluating Zyesami and Remdesivir in critical COVID-19 patients as monotherapy, and in combination…
Volunteers in Russia’s Sputnik V vaccine trials will no longer receive placebos – RIA Reuters Dec 23, 2020 Interim trial data published last week found Sputnik V, which Russian regulators approved in August after less than two months of…
